The investment seeks long-term capital growth... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 22.90 | 0.18 | +0.79% |
| Saratoga Health & Biotechnology I | |||
| FCUIX | 20.41 | 0.03 | +0.15% |
| NYLI PineStone U.S. Equity Class I | |||
| ASERX | 120.94 | -0.40 | -0.33% |
| American Century Select R | |||
| MUETX | 38.86 | -0.14 | -0.36% |
| MFS Blended Research Core Equity R3 | |||
| FISGX | 41.43 | -0.15 | -0.36% |
| Nuveen Small/Mid Cap Growth Opp I | |||
A.I.dvisor indicates that over the last year, VRLCX has been closely correlated with VIGAX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if VRLCX jumps, then VIGAX could also see price increases.
| Ticker / NAME | Correlation To VRLCX | 1D Price Change % | ||
|---|---|---|---|---|
| VRLCX | 100% | -0.39% | ||
| VIGAX - VRLCX | 91% Closely correlated | -0.34% | ||
| VIGIX - VRLCX | 91% Closely correlated | -0.33% | ||
| VIGRX - VRLCX | 91% Closely correlated | -0.33% | ||
| RGACX - VRLCX | 85% Closely correlated | -0.07% | ||
| GFFFX - VRLCX | 85% Closely correlated | -0.07% | ||
More | ||||